James Leal - Jun 2, 2021 Form 3 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
SVP, Operations
Signature
s/ David B. Berger, Attorney-in-Fact for James A. Leal
Stock symbol
TNDM
Transactions as of
Jun 2, 2021
Transactions value $
$0
Form type
3
Date filed
6/10/2021, 04:55 PM
Next filing
Jun 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TNDM Common Stock 3.6K Jun 2, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNDM Stock Option Jun 2, 2021 Common Stock 835 $251.34 Direct F1, F2, F3
holding TNDM Stock Option Jun 2, 2021 Common Stock 59 $251.34 Direct F1, F2, F3
holding TNDM Stock Option Jun 2, 2021 Common Stock 1.3K $150.00 Direct F3, F4, F5
holding TNDM Stock Option Jun 2, 2021 Common Stock 8.8K $150.00 Direct F3, F4, F5
holding TNDM Stock Option Jun 2, 2021 Common Stock 800 $119.20 Direct F3, F4, F6
holding TNDM Stock Option Jun 2, 2021 Common Stock 1.46K $119.20 Direct F3, F4, F6
holding TNDM Stock Option Jun 2, 2021 Common Stock 3.39K $69.50 Direct F3, F4, F7
holding TNDM Stock Option Jun 2, 2021 Common Stock 468 $9.00 Direct F3, F4, F8
holding TNDM Stock Option Jun 2, 2021 Common Stock 40K $51.50 Direct F3, F4, F9
holding TNDM Stock Option Jun 2, 2021 Common Stock 11.4K $82.34 Direct F3, F4, F10
holding TNDM Restricted Stock Unit Jun 2, 2021 Common Stock 3.72K $0.00 Direct F4, F11
holding TNDM Stock Option Jun 2, 2021 Common Stock 4.1K $81.63 Direct F3, F4, F12
holding TNDM Restricted Stock Unit Jun 2, 2021 Common Stock 2.68K $0.00 Direct F4, F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the Tandem Diabetes Care, Inc. 2006 Stock Incentive Plan.
F2 The date of grant of the option was 01/30/2012. All shares subject to the option have vested.
F3 The expiration date for these options is 10 years from the date of grant.
F4 Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F5 The date of grant of the option was 11/13/2013. All shares subject to the option have vested.
F6 The date of grant of the option was 05/21/2015. All shares subject to the option have vested.
F7 The date of grant of the option was 02/16/2016. All shares subject to the option have vested.
F8 The date of grant of the option was 05/17/2017. All shares subject to the option have vested.
F9 The date of grant of the option was 02/15/2019. 25% of the shares subject to the option vested on 02/15/2020 and the remainder vests in 36 equal monthly installments thereafter.
F10 The date of grant of the option was 05/27/2020. 25% of the shares subject to the option vested on 05/27/2021 and the remainder vests in 36 equal monthly installments thereafter.
F11 The date of Restricted Stock Unit ("RSU") grant was 05/27/2020. RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F12 The date of grant of the option was 05/18/2021. 25% of the shares subject to the option will vest on 05/18/2022 and the remainder vests in 36 equal monthly installments thereafter.
F13 The date of Restricted Stock Unit ("RSU") grant was 05/18/2021. RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 05/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.